[
    [
        {
            "time": "",
            "original_text": "一季度MNC在华销售猛增29%！辉瑞、诺华、AZ……谁有最强增长引擎？4+7风暴影响几何？",
            "features": {
                "keywords": [
                    "MNC",
                    "销售猛增",
                    "辉瑞",
                    "诺华",
                    "AZ",
                    "4+7",
                    "增长引擎"
                ],
                "sentiment_score": 0.7,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "一季度MNC在华销售猛增29%！辉瑞、诺华、AZ……谁有最强增长引擎？4+7风暴影响几何？",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 7,
                "Market_Scope": 7,
                "Time_Proximity": 6,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "上海国资改革大动作将至，69只国资股一图尽览",
            "features": {
                "keywords": [
                    "上海",
                    "国资改革",
                    "69只国资股"
                ],
                "sentiment_score": 0.8,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "国企改革"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "上海国资改革大动作将至，69只国资股一图尽览",
                "Correlation": 7,
                "Sentiment": 6,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 5,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "不甘示弱！6家药企巨头2018营收增速超20%",
            "features": {
                "keywords": [
                    "药企巨头",
                    "营收增速",
                    "2018",
                    "20%"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "不甘示弱！6家药企巨头2018营收增速超20%",
                "Correlation": 7,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 6,
                "Market_Scope": 6,
                "Time_Proximity": 5,
                "Headline_Structure": 8,
                "Source_Recency": 5
            }
        }
    ]
]